Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tofacitinib Oral Solution
DRUG
2 trials
Sponsors
Pfizer
, University of Colorado, Denver
Conditions
Down Syndrome
Healthy
Phase 1
A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants.
Completed
NCT04111614
Pfizer
Healthy
Start: 2019-10-11
End: 2019-12-12
Updated: 2020-01-13
Phase 2
Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1
Recruiting
NCT07598643
University of Colorado, Denver
Down Syndrome
Start: 2026-05-28
End: 2030-08-01
Target: 92
Updated: 2026-09-03
Related Papers
Tofacitinib pharmacokinetics in children and adolescents with juvenile idiopathic arthritis
CPT Pharmacometrics & Systems Pharmacology
2024-01-31
6 citations